Related Experiment Video
Updated: Jun 14, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Brain Atrophy in Dogs With Meningoencephalitis of Unknown Origin
Rita Gonçalves1,2, Gemma Walmsley1,2, Thomas W Maddox1,2
1Department of Veterinary Science, Small Animal Teaching Hospital, University of Liverpool, Leahurst, Neston, UK.
Background:
Information regarding repeat magnetic resonance imaging (MRI) findings in dogs with meningoencephalitis of unknown origin (MUO) is sparse and it is unknown whether brain atrophy occurs.
Objectives:
To determine whether brain atrophy occurs in MUO and evaluate if there is an association between atrophy and survival or relapse.
Animals:
Twenty-three dogs diagnosed with MUO that underwent MRI of the brain on two occasions at least six months apart.
Methods:
Retrospective study. Interthalamic adhesion thickness to brain height ratio (ITr), lateral ventricle to brain height ratio (LVr), interthalamic adhesion thickness/brain height to lateral ventricle/brain height (ITr/LVr), bicaudate ratio (BCR) and total parenchymal brain volume (TPBV) were measured on both MRI studies and compared.
Results:
Thirteen dogs relapsed and four died during the study period. Median time between MRIs was 12 months, and only one imaging study (1/23) was considered normal on the second scan. All MRI variables measured significantly changed between imaging studies, but only higher TPBV was associated with increased survival (OR = 1.59, CI = 1.006-2.51, p = 0.047); no variables were found to be associated with relapse. New lesions were identified in six dogs (four of which also showed contrast enhancing lesions), with 5/6 of these dogs subsequently relapsing.
Conclusions And Clinical Importance:
Brain atrophy likely occurs in dogs with MUO and is associated with worse outcomes. Clinical relapse might be likely in dogs with new or contrast-enhancing lesions on repeat MRI, so more aggressive treatment should be considered in these dogs.
Insights
Brain atrophy likely occurs in dogs with meningoencephalitis of unknown origin (MUO), as shown by repeat MRI scans. This brain atrophy is linked to poorer outcomes and may indicate a need for more aggressive treatment strategies.
Area of Science:
- Veterinary Neurology
- Neuroimaging
Background:
- Information on repeat magnetic resonance imaging (MRI) findings in dogs with meningoencephalitis of unknown origin (MUO) is limited.
- It remains unclear if brain atrophy develops in canine MUO cases.
Purpose of the Study:
- To investigate the occurrence of brain atrophy in dogs diagnosed with MUO.
- To assess the association between brain atrophy and survival rates or disease relapse in these dogs.
Main Methods:
- A retrospective study involving 23 dogs with MUO who underwent two brain MRI scans at least six months apart.
- Quantitative MRI metrics, including interthalamic adhesion to brain height ratio (ITr), lateral ventricle to brain height ratio (LVr), bicaudate ratio (BCR), and total parenchymal brain volume (TPBV), were measured and compared between scans.
Main Results:
- Thirteen dogs experienced relapse, and four died during the study. All measured MRI variables showed significant changes between the two scans.
- Increased total parenchymal brain volume (TPBV) was associated with enhanced survival (OR=1.59, P=0.047). No specific MRI variables correlated with relapse.
- New or contrast-enhancing lesions on repeat MRI were observed in six dogs, five of whom subsequently relapsed.
Conclusions:
- Brain atrophy is likely present in dogs with MUO and correlates with adverse outcomes.
- The presence of new or contrast-enhancing lesions on repeat MRI may predict clinical relapse, suggesting a need for intensified therapeutic approaches.
Related Concept Videos
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction
Alzheimer Disease ll: Pathophysiology
Hepatic Encephalopathy

